Antivirals for Influenza

The dominant circulating Flu strain for 2018-19 season has been identified as Influenza A(H1N1).

Zanamavir should be used first line for patients that are severely immunosuppressed instead of Oseltamivir (Tamiflu).

Further information available link to guidance.

 

Antiviral advice can be found here

From PHE Guidance on use of antiviral agents for the treatment and prophylaxis of influenza 2017